Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/05/2012EP2495238A1 Novel 3-hydroxy-5-arylisoxazole derivative
09/05/2012EP2495236A1 Benzazepine compound
09/05/2012EP2495016A1 Bicyclic Heteroaryl Compounds
09/05/2012EP2494992A1 Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
09/05/2012EP2494991A1 Combination therapy for the treatment of HCV infection
09/05/2012EP2494990A1 Agent for regeneration and/or protection of nerves
09/05/2012EP2494989A1 Photodynamic therapy for the treatment of acne
09/05/2012EP2494980A2 Medical utility of glycans
09/05/2012EP2494976A1 Methods for the treatment of a traumatic central nervous system injury
09/05/2012EP2494975A1 Compounds and methods for promoting smoking cessation
09/05/2012EP2494974A1 Method for treating tuberculosis
09/05/2012EP2494973A1 Topical compositions for the treatment and prevention of skin diseases, in particular radiation dermatitis caused by ionising radiation
09/05/2012EP2494972A2 Use of gambierol for treating and/or preventing neurodegenerative diseases related to tau and beta-amyloid
09/05/2012EP2494971A1 Gambogic acid derivatives, preparative methods and uses thereof
09/05/2012EP2494969A1 Pharmaceutical formulations of HDAC inhibitors
09/05/2012EP2494968A1 Compound, in particular dermatological ointment with Olea Europaea Fruit Oil and Silver
09/05/2012EP2494967A1 Novel composition for treating metabolic syndrome
09/05/2012EP2494966A1 Stable composition of rasagiline
09/05/2012EP2494965A2 Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-EGFR Therapy
09/05/2012EP2494964A1 Combinations of valsartan and amlodipine
09/05/2012EP2494963A1 Combinations of valsartan and amlodipine
09/05/2012EP2494962A2 Pulmonary delivery for levodopa
09/05/2012EP2494961A1 Drug formulations having reduced abuse potential
09/05/2012EP2494957A1 Submicro emulsion of paclitaxel using steroid complex as intermediate carrier
09/05/2012EP2494956A1 Paclitaxel/steroidal complex
09/05/2012EP2494955A2 Stable liquid pharmaceutical composition based on trazodone
09/05/2012EP2494954A2 Ophthalmic composition based on lactobionic acid useful for reducing corneal edema and inflammation
09/05/2012EP2494049A2 Methods and compositions for dysferlin exon-skipping
09/05/2012EP2494048A1 Method of treatment
09/05/2012EP2493942A2 Polymeric materials including a glycosaminoglycan networked with a polyolefin-containing polymer
09/05/2012EP2493905A1 Bisphosphonate compounds for treating bone metabolism disorders
09/05/2012EP2493897A1 Hydroxy-substituted gold(iii) porphyrin complexes as histone deacetylase inhibitors
09/05/2012EP2493896A1 Pharmaceutical composition containing cyclometalated n-heterocyclic carbene complexes for cancer treatment
09/05/2012EP2493895A1 N-containing heteroaryl derivatives as jak3 kinase inhibitors
09/05/2012EP2493894A1 Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
09/05/2012EP2493893A1 Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
09/05/2012EP2493892A1 Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
09/05/2012EP2493889A1 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
09/05/2012EP2493888A1 Bicyclic pyridines and analogs as sirtuin modulators
09/05/2012EP2493879A2 Dimeric smac mimetics
09/05/2012EP2493878A1 Pyrazines as delta opioid receptor modulators
09/05/2012EP2493877A1 Pyrimidine compounds as delta opioid receptor modulators
09/05/2012EP2493876A1 Imidazole derivatives as casein kinase inhibitors
09/05/2012EP2493875A1 Heterocyclic compounds as ccr1 receptor antagonists
09/05/2012EP2493874A1 Novel crystalline forms of (3r,6r) -3- (2, 3 -dihydro- 1h- inden- 2 -yl) - 1 - [ (1r) - 1 - (2, 6 - dimethyl - 3 - pyridinyl) - 2 - (4 -morpholinyl) -2-oxoethyl]-6- [(1s) - 1 -methylpropyl]-2,5- piperazinedione
09/05/2012EP2493873A1 Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof
09/05/2012EP2493871A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
09/05/2012EP2493870A1 Chromenone derivatives with anti-tumour activity
09/05/2012EP2493867A1 Process for making crystalline form a of linezolid
09/05/2012EP2493866A1 Tricyclic heterocyclic compounds
09/05/2012EP2493865A2 Raf inhibitor compounds and methods of use thereof
09/05/2012EP2493864A1 N-oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea
09/05/2012EP2493863A1 Phenoxy-substituted pyrimidines as opioid receptor modulators
09/05/2012EP2493862A1 Imidazole derivatives as ido inhibitors
09/05/2012EP2493861A1 Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone
09/05/2012EP2493859A1 New compounds for the treatment of diseases related to protein misfolding
09/05/2012EP2493858A1 Androgen receptor modulating compounds
09/05/2012EP2493857A1 9-aminoacridine derivatives, their preparation and uses
09/05/2012EP2493856A1 Positive allosteric modulators (pam)
09/05/2012EP2493855A1 (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
09/05/2012EP2493852A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
09/05/2012EP2493851A2 Closthioamides
09/05/2012EP2493846A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
09/05/2012EP2493845A1 Substituted 3-phenylpropionic acids and the use thereof
09/05/2012EP2493573A1 Use of ferroquine in the treatment or prevention of malaria
09/05/2012EP2493572A1 Angiogenesis promoted by caged growth factors
09/05/2012EP2493571A1 Alkynyl derivatives useful as dpp-1 inhibitors
09/05/2012EP2493509A2 Aqueous composition for topical application, method of preparation, uses and device
09/05/2012EP2493508A2 Transdermal pharmaceutical compositions comprising active agents
09/05/2012EP2493488A1 Preparation comprising amino acids and plants and its activity in the alcohol detoxification
09/05/2012EP2493484A2 Gastroretentive oral high dose zinc preparations
09/05/2012EP2493483A2 Rosacea topical skin treatment method and formulation
09/05/2012EP2493481A1 Anti-cancer composition comprising alginate
09/05/2012EP2493480A1 Ophthalmic formulation and method of manufacture thereof
09/05/2012EP2493479A1 Methods of treating viral associated diseases
09/05/2012EP2493478A1 Concentrated therapeutic phospholipid compositions
09/05/2012EP2493477A2 Bazedoxifene formulations with antioxidants
09/05/2012EP2493476A1 Deuterated 5,6-dihydro-1h-pyridin-2-one compounds
09/05/2012EP2493475A2 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
09/05/2012EP2493474A2 Methods and compositions for sustained delivery of drugs
09/05/2012EP2493473A1 Dosing regimen associated with long-acting injectable paliperidone esters
09/05/2012EP2493472A1 Methods of synthesis and purification of heteroaryl compounds
09/05/2012EP2493471A1 Novel enteric combination therapy
09/05/2012EP2493470A1 Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin
09/05/2012EP2493469A2 Pharmaceutical composition comprising indole compound
09/05/2012EP2493468A1 Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders
09/05/2012EP2493467A1 Compositions including pyruvate for companion animals and methods of use thereof
09/05/2012EP2493466A1 Novel antitumoral use of cabazitaxel
09/05/2012EP2493465A2 Treatment of sunburn using analgesics and antihistamines
09/05/2012EP2493464A1 Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
09/05/2012EP2493463A1 Use of menthyl ethers as anti-bacterial, anti-mycotic or anti-viral active substances
09/05/2012EP2493462A1 Pterostilbene (pter) for use in the prevention and/or treatment of skin diseases, damages or injures
09/05/2012EP2493461A1 Therapeutic uses of oligomeric and polymeric monoterpenes
09/05/2012EP2493460A1 Methods and compositions for treating cancer
09/05/2012EP2493457A1 Fast dissolving solid dosage form
09/05/2012EP2493456A2 Solid dispersion of rifaximin
09/05/2012EP2493455A1 Composition comprising fesoterodine and fiber
09/05/2012EP2493453A1 Use of biocompatible compositions and materials polymerized therefrom for inhibiting angiogenesis
09/05/2012EP2493442A2 Devices, methods, and composition for controlling infections
09/05/2012EP2493333A2 Stable thickener formulations
1 ... 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 ... 7860